Artiva Biotherapeutics (ARTV) Total Liabilities (2023 - 2025)
Historic Total Liabilities for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $19.6 million.
- Artiva Biotherapeutics' Total Liabilities fell 2017.07% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year decrease of 2017.07%. This contributed to the annual value of $22.9 million for FY2024, which is 5476.77% down from last year.
- As of Q3 2025, Artiva Biotherapeutics' Total Liabilities stood at $19.6 million, which was down 2017.07% from $20.3 million recorded in Q2 2025.
- Artiva Biotherapeutics' 5-year Total Liabilities high stood at $174.7 million for Q1 2024, and its period low was $19.6 million during Q3 2025.
- In the last 3 years, Artiva Biotherapeutics' Total Liabilities had a median value of $37.6 million in 2024 and averaged $70.2 million.
- Examining YoY changes over the last 5 years, Artiva Biotherapeutics' Total Liabilities showed a top increase of 2017.07% in 2025 and a maximum decrease of 8713.02% in 2025.
- Artiva Biotherapeutics' Total Liabilities (Quarter) stood at $50.7 million in 2023, then crashed by 54.77% to $22.9 million in 2024, then dropped by 14.39% to $19.6 million in 2025.
- Its Total Liabilities was $19.6 million in Q3 2025, compared to $20.3 million in Q2 2025 and $22.5 million in Q1 2025.